• Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

  • Aug 5 2024
  • Length: 28 mins
  • Podcast

Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

Listen for free

View show details

  • Summary

  • Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse.

    Read the full article:
    https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
Show more Show less

What listeners say about Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available